We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-0.97%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.62B
AUM Growth
+$104M
(+3%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
18.9%
Holding
1,521
New
107
Increased
774
Reduced
496
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$16.7M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$13.5M |
| 3 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$10M |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
+$9.41M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$8.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.1M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$13.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$13.1M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$9.94M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$7.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.26% |
| 2 | Financials | 5.23% |
| 3 | Healthcare | 4.75% |
| 4 | Energy | 4.61% |
| 5 | Industrials | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
ProShares Short 20+ Year Treasury ETF
TBF
$107M
| $1.41M | 0.04% |
53,918
-3,812
| -7% | -$96.7K |
|
402
Vertex Pharmaceuticals
VRTX
$133B
| $1.41M | 0.04% |
11,439
+3,543
| +45% | +$446K |
|
403
iShares Global Healthcare ETF
IXJ
$4.24B
| $1.41M | 0.04% |
25,856
+3,778
| +17% | +$208K |
|
404
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
| $1.4M | 0.04% |
58,028
+8,034
| +16% | +$202K |
|
405
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $1.4M | 0.04% |
28,752
-1,052
| -4% | -$51.2K |
|
406
WisdomTree US High Dividend Fund
DHS
$1.57B
| $1.4M | 0.04% |
23,532
-5,284
| -18% | -$323K |
|
407
Nucor
NUE
$62.5B
| $1.4M | 0.04% |
31,691
+1,418
| +5% | +$68.1K |
|
408
Teva Pharmaceuticals
TEVA
$42.1B
| $1.39M | 0.04% |
23,488
+1,769
| +8% | +$109K |
|
409
eBay
EBAY
$47.9B
| $1.39M | 0.04% |
54,653
-6,681
| -11% | -$167K |
|
410
iShares Morningstar Small-Cap Value ETF
ISCV
$704M
| $1.38M | 0.04% |
32,919
+831
| +3% | +$36K |
|
|
SDRL
411
DELISTED
Seadrill Limited Common Stock
SDRL
| $1.37M | 0.04% |
495
+50
| +11% | +$161K |
|
|
ETV
412
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.77B
| $1.37M | 0.04% |
92,181
+11,960
| +15% | +$181K |
|
413
Weyerhaeuser
WY
$18.2B
| $1.37M | 0.04% |
43,397
+5,114
| +13% | +$164K |
|
414
State Street SPDR S&P Pharmaceuticals ETF
XPH
$512M
| $1.35M | 0.04% |
21,686
+434
| +2% | +$27K |
|
|
MON
415
DELISTED
Monsanto Co
MON
| $1.35M | 0.04% |
12,658
-461
| -4% | -$53.5K |
|
416
Alcoa
AA
$13.6B
| $1.34M | 0.04% |
50,062
+940
| +2% | +$29.1K |
|
|
KSU
417
DELISTED
Kansas City Southern
KSU
| $1.34M | 0.04% |
14,665
+2,161
| +17% | +$213K |
|
418
National Grid
NGG
$79.9B
| $1.33M | 0.04% |
21,400
-530
| -2% | -$34.7K |
|
419
Prudential Financial
PRU
$42.1B
| $1.33M | 0.04% |
15,148
-257
| -2% | -$21.8K |
|
|
K
420
DELISTED
Kellanova
K
| $1.32M | 0.04% |
22,418
-1,281
| -5% | -$76.6K |
|
421
Energy Transfer Partners
ET
$70.9B
| $1.32M | 0.04% |
41,022
+1,954
| +5% | +$65.5K |
|
422
First Trust Technology AlphaDEX Fund
FXL
$2.78B
| $1.32M | 0.04% |
37,234
+9,117
| +32% | +$333K |
|
423
Capital One
COF
$134B
| $1.31M | 0.04% |
14,847
+306
| +2% | +$25.7K |
|
424
Middleby
MIDD
$5.89B
| $1.3M | 0.04% |
11,600
-147
| -1% | -$15.7K |
|
425
iShares US Technology ETF
IYW
$25.3B
| $1.3M | 0.04% |
49,664
-129,836
| -72% | -$3.5M |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, Cambridge Investment Research Advisors held 1,521 positions worth $3.62B, up 3% from $3.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors deployed $157M of net new capital in Q2 2015, opening 107 new positions and adding to 774 existing holdings. Its largest new stake was iShare MSCI Eurozone ETF: 75,058 shares worth $2.82M.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $15.1M trimmed.
- Cambridge Investment Research Advisors's largest Q2 2015 buy was iShare MSCI Eurozone ETF: 75,058 shares worth $2.82M.
- Cambridge Investment Research Advisors added most to iShares MSCI EAFE ETF in Q2 2015, an estimated $16.7M increase.
- Cambridge Investment Research Advisors's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $15.1M.
- Cambridge Investment Research Advisors fully exited Monster Beverage in Q2 2015, selling an estimated $3.19M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $3.62B portfolio in Q2 2015.
- Cambridge Investment Research Advisors opened 107 new positions and closed 73 in Q2 2015.
- Cambridge Investment Research Advisors's portfolio value rose 3% quarter-over-quarter to $3.62B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.